Skip to main content
Terug
Watch Compare

BIOHARVEST SCIENCES INC.

Datakwaliteit: 83%
BHST
NASDAQ Manufacturing Chemicals
€ 4,27
▼ € 0,03 (-0,70%)
6 months return
—
Momentum
Neutral
ROE
-83,17%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)37,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-83,17%
Onder sectorgemiddelde (-54,68%)
ROICN/A
Net Margin-32,27%
Op. Margin-16,16%

Veiligheid

Debt / Equity
0,01
Onder sectorgemiddelde (0,30)
Current Ratio3,97
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-8,79 | -55,48
Onder sectorgemiddelde (-1,49)
P/B Ratio3,85
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -9,58 M
Capital efficient — spends only 6,82% of revenue on capex

Price History

Financiële Trends

Koersdoel Analisten

4 analisten
Buy
+198.6%
upside to target
Huidig
€ 4,27
Consensus Target
€ 12,75
€ 10,00
Laag
€ 15,00
Hoog
Vooruitzicht
Forward K/W
-55,48
Forward WPA
-€ 0,08
Omzet Sch.
60,69 M

Winstverassingen

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -€ 0,10 · Rev Est: 9,25 M
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -€ 0,13 -€ 0,24 -€ 0,14 -€ 0,10 — —
Estimate -€ 0,12 -€ 0,11 -€ 0,12 -€ 0,11 -€ 0,10 -€ 0,10
Verrassing -8,33% -123,26% -21,74% +4,76% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) 37,00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -83,17% · Net Margin: -32,27%
Revenue (TTM) 34,51 M Net Income (TTM) -11,14 M
ROE -83,17% ROA N/A
Gross Margin N/A Operating Margin -16,16%
Net Margin -32,27% Free Cash Flow (TTM) -9,58 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: 0,01 · Current: 3,97
Debt / Equity 0,01 Current Ratio 3,97
Interest Coverage N/A Asset Turnover N/A
Working Capital 22,82 M Tangible Book Value 25,45 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -8,79 · EV/EBITDA: N/A
P/E Ratio -8,79 Forward P/E -55,48
P/B Ratio 3,85 P/S Ratio 2,84
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1,61 Fwd Earnings Yield N/A
FCF Yield -9,78%
Market Cap 97,93 M Enterprise Value 75,05 M

Per Share

EPS: N/A · FCF/Share: -0,42
EPS (Diluted TTM) N/A Revenue / Share 1,52
FCF / Share -0,42 OCF / Share -0,32
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 86,04% · CapEx/Rev: 6,82%
CapEx / Revenue 6,82% FCF Conversion 86,04%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 34,51 M 25,19 M
Net Income -11,14 M -12,91 M
EPS (Diluted) — —
Gross Profit — —
Operating Income -5,58 M -6,99 M
EBITDA — —
R&D Expenses — —
SG&A Expenses — —
D&A 1,62 M 1,25 M
Interest Expense — —
Income Tax -76.000,0 8.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets — —
Total Liabilities — —
Shareholders' Equity 25,45 M 1,33 M
Total Debt 149.000,0 3,91 M
Cash & Equivalents 23,03 M 2,39 M
Current Assets 30,50 M 7,86 M
Current Liabilities 7,68 M 14,26 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -8,8 -1,5
P/B 3,9 1,6
ROE % -83,2 -54,7
Net Margin % -32,3 -41,5
Rev Growth 5Y % — 1,7
D/E 0,0 0,3